Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal, Anna Sokolovska, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 322

Showing 1-25 of 322 citing articles:

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
Jun Zhou, Maoyi Li, Qiufang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 383
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 285
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, J Filderman, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2695-2695
Open Access | Times Cited: 284
Bacteria‐Based Cancer Immunotherapy
Xuehui Huang, Jingmei Pan, Funeng Xu, et al.
Advanced Science (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 243
Engineering living therapeutics with synthetic biology
Andrés Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 941-960
Closed Access | Times Cited: 223
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 4, pp. 677-688
Open Access | Times Cited: 219
Engineering bacteria as interactive cancer therapies
Candice R. Gurbatri, Nicholas Arpaia, Tal Danino
Science (2022) Vol. 378, Iss. 6622, pp. 858-864
Open Access | Times Cited: 219
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 218
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 195
Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
Zhaoting Li, Yixin Wang, Jun Liu, et al.
Advanced Materials (2021) Vol. 33, Iss. 38
Closed Access | Times Cited: 178
Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery
Mukrime Birgul Akolpoglu, Yunus Alapan, Nihal Olcay Dogan, et al.
Science Advances (2022) Vol. 8, Iss. 28
Open Access | Times Cited: 175
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 166
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 161
Ultrasound-controllable engineered bacteria for cancer immunotherapy
Mohamad H. Abedi, Michael S. Yao, David R. Mittelstein, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 160
Delivery of STING agonists for adjuvanting subunit vaccines
Simon Van Herck, Bing Feng, Li Tang
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114020-114020
Open Access | Times Cited: 126
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
Avinoam Bar‐Zion, Atousa Nourmahnad, David R. Mittelstein, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 12, pp. 1403-1412
Open Access | Times Cited: 116
Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 116
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 112
Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth
Jialu Xu, Qingle Ma, Yue Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
An Engineered Bacteria-Hybrid Microrobot with the Magnetothermal Bioswitch for Remotely Collective Perception and Imaging-Guided Cancer Treatment
Haotian Chen, Yingze Li, Yanjin Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6118-6133
Closed Access | Times Cited: 86
Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria
Robert C. Hurt, Marjorie T. Buss, Mengtong Duan, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 919-931
Open Access | Times Cited: 84
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells
Liliana M. Sanmarco, Joseph M. Rone, Carolina Manganeli Polonio, et al.
Nature (2023) Vol. 620, Iss. 7975, pp. 881-889
Closed Access | Times Cited: 77
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Jason J. Luke, Sarina A. Piha‐Paul, Theresa Medina, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 13, pp. 2435-2444
Open Access | Times Cited: 70
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top